Literature DB >> 9753197

Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells.

F W Holtsberg1, M R Steiner, A J Bruce-Keller, J N Keller, M P Mattson, J C Moyers, S M Steiner.   

Abstract

The lipid biomediator lysophosphatidic acid (LPA) elicits a unique response in hippocampal neurons, LPA induces neuronal apoptosis. This study explores the effects of LPA on cells with neuronal properties, nerve growth factor-differentiated PC6 cells, a clone of PC12 cells. LPA induced apoptosis in these cells as assessed by chromatin condensation, terminal dUTP nick end-labeling of DNA, protection against these nuclear alterations by a general caspase inhibitor and the lack of release of lactic dehydrogenase. LPA caused oxidative stress, namely a decreased reduction of MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. This oxidative stress appears to be of functional significance, since cells were protected by pretreatment with the antioxidant propyl gallate and by stable transfection with cDNA encoding the antioxidant enzyme, manganese superoxide dismutase. Mitochondrial and nitric oxide participation in LPA-induced apoptosis are suggested by the protection afforded by pretreatment with either cyclosporin A, an inhibitor of mitochondrial permeability transition, or nitric oxide synthase inhibitors. The nitric oxide synthase inhibitor findings are novel, since to our knowledge, LPA has not heretofore been associated with an increase in nitric oxide. In addition, as observed for many neurotoxic agents, insulin-like growth factor I protected against LPA-induced apoptosis of PC6 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753197     DOI: 10.1002/(SICI)1097-4547(19980915)53:6<685::AID-JNR7>3.0.CO;2-1

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Down-regulation of inducible nitric oxide synthase by lysophosphatidic acid in human respiratory epithelial cells.

Authors:  Saori Kadowaki; Hiroki Chikumi; Hiroyuki Yamamoto; Kazuhiko Yoneda; Akira Yamasaki; Kenzo Sato; Eiji Shimizu
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

2.  Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.

Authors:  X Fang; S Yu; R LaPushin; Y Lu; T Furui; L Z Penn; D Stokoe; J R Erickson; R C Bast; G B Mills
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

3.  A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.

Authors:  Geneviéve Gueguen; Virginie Granci; Pierre Rogalle; Fabienne Briand-Mésange; Michéle Wilson; Alain Klaébé; François Tercé; Hugues Chap; Jean-Pierre Salles; Marie-Françoise Simon; Frédérique Gaits
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

Review 4.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

5.  Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21.

Authors:  Yunzhou Dong; Yong Wu; Mei-Zhen Cui; Xuemin Xu
Journal:  Mediators Inflamm       Date:  2017-02-19       Impact factor: 4.711

6.  The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model.

Authors:  Yukiko Tando; Chiharu Ota; Mitsuhiro Yamada; Satoshi Kamata; Mutsuo Yamaya; Kuniyuki Kano; Shinichi Okudaira; Junken Aoki; Hiroshi Kubo
Journal:  Transplant Direct       Date:  2015-10-19

7.  Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease.

Authors:  Shahzad Ahmad; Adelina Orellana; Isabelle Kohler; Lutz Frölich; Itziar de Rojas; Silvia Gil; Mercè Boada; Isabel Hernández; Lucrezia Hausner; Margot H M Bakker; Alfredo Cabrera-Socorro; Najaf Amin; Alfredo Ramírez; Agustín Ruiz; Thomas Hankemeier; Cornelia M Van Duijn
Journal:  Alzheimers Res Ther       Date:  2020-10-02       Impact factor: 6.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.